Litcius/Paper detail

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

Ka-Tim Choy, Alvina Y. L. Wong, Prathanporn Kaewpreedee, Sin Fun Sia, Dongdong Chen, Kenrie Pui Yan Hui, Daniel K. W. Chu, Michael C. W. Chan, Peter Pak‐Hang Cheung, Xuhui Huang, Malik Peiris, Hui‐Ling Yen

2020Antiviral Research972 citationsDOIOpen Access PDF

Topics & Concepts

EmetineFavipiravirLopinavirHomoharringtonineVero cellPharmacologyIn vitroVirologyMedicineRibavirinViral replicationVirusChloroquineViral loadChemistryCoronavirus disease 2019 (COVID-19)ImmunologyInternal medicineBiochemistryMyeloid leukemiaInfectious disease (medical specialty)MalariaHepatitis C virusAntiretroviral therapyDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRespiratory viral infections research
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro | Litcius